IIPLA News
Tuesday, June 9, 2026

Dreamology Labs Sues MSC Cruises for Nearly $2 Billion Over Alleged IP Misappropriation

Italian entrepreneur Alessandra Maderni accuses MSC Cruises of unauthorized use of confidential entertainment concepts and technologies

IIPLA News Deskanonymous access0 articles left this week
Dreamology Labs Sues MSC Cruises for Nearly $2 Billion Over Alleged IP Misappropriation

Italian entrepreneur Alessandra Maderni, founder of Dreamology Labs, has filed a substantial intellectual property lawsuit against MSC Cruises, its U.S. division, and executive chairman Pierfrancesco Vago. The complaint, filed in the United States, seeks damages approaching $2 billion.

According to the legal filing, Dreamology Labs engaged with MSC Cruises over several years, from 2019 through 2025, sharing a variety of projects, ideas, and technological innovations focused on enhancing onboard entertainment and passenger experiences. These exchanges were conducted under strict confidentiality agreements.

Dreamology Labs alleges that MSC Cruises subsequently utilized portions of this confidential material to develop new attractions and concepts deployed on its cruise ships. The company contends that this use occurred without authorization, recognition, or any form of financial remuneration.

The lawsuit enumerates several claims against MSC Cruises, including misuse of trade secrets, copyright infringement, breach of confidentiality agreements, and other irregular business practices deemed unlawful by Dreamology Labs.

In response, MSC Cruises has categorically denied all allegations. The cruise line issued a statement affirming its intention to vigorously defend its interests in court. Furthermore, MSC Cruises indicated it may pursue legal action against Dreamology Labs and its director, citing what it characterizes as false and defamatory statements.

The case remains in the judicial phase with no resolution yet reached. The final determination of damages, if any, will be established through the ongoing legal process.

This dispute highlights the complexities surrounding intellectual property rights in the cruise industry, particularly concerning innovations in passenger entertainment and experience.

As the litigation proceeds, industry observers will be watching closely for any precedent-setting outcomes related to the protection of trade secrets and confidential business information.

MSC Cruises continues its operations amid the legal challenge, maintaining its stance against the allegations.

Meanwhile, Dreamology Labs seeks recognition and compensation for what it asserts is the unauthorized exploitation of its proprietary concepts.

The lawsuit underscores the importance of clear contractual terms and vigilant protection of intellectual property in collaborative business ventures.

Both parties await the court’s determination, which will clarify the scope of intellectual property protections applicable to their dispute.

Share This Article
Ready-to-post copy includes the article link.

Dreamology Labs Sues MSC Cruises for Nearly $2 Billion Over Alleged IP Misappropriation Dreamology Labs, led by Alessandra Maderni, has initiated a $2 billion lawsuit in the U.S. against MSC Cruises and its executive chairman, Pierfrancesco Vago. The suit alleges that MSC Cruises exploited confidential pro... Read the full IIPLA article: https://iipla.org/news/dreamology-labs-sues-msc-cruises-for-nearly-2-billion-over-alleged-ip-misappropriation

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026